Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Yarrow Bioscience, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −1 vs. Q4 2023
- Shares held
- 7.84M
- −64.4K (−0.8%) vs. Q4 2023
- Total value
- $22.9M
- +$4.50M (+24.4%) vs. Q4 2023
- New holders
- 5
- 8 more added
- Sold out
- 6
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 1,394,336 | $4.28M | 0.19% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,181,088 | $3.63M | 0.00% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 1,394,336 | $3.13M | 0.05% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 696,470 | $2.14M | 0.26% | 00.0% | Unchanged |
| DSC Advisors, L.P. | 696,465 | $2.14M | 3.45% | 00.0% | Unchanged |
| Palo Alto Investors LP | 445,434 | $1.37M | 0.15% | 00.0% | Unchanged |
| AlphaCentric Advisors LLC | 445,000 | $1.37M | 0.82% | −223,151−33.4% | Reduced |
| Exome Asset Management LLC | 415,434 | $1.28M | 1.09% | +297,334+251.8% | Added |
| Schonfeld Strategic Advisors LLC | 219,800 | $674.8K | 0.01% | +219,800 | New |
| Royal Bank of Canada | 175,372 | $538.0K | 0.00% | +174,107+13,763.4% | Added |
| ADAR1 Capital Management, LLC | 110,091 | $338.0K | 0.09% | +110,091 | New |
| Geode Capital Management, LLC | 106,775 | $327.8K | 0.00% | +12,432+13.2% | Added |
| Prelude Capital Management, LLC | 94,600 | $290.4K | 0.02% | −23,500−19.9% | Reduced |
| Silverarc Capital Management, LLC | 86,383 | $265.2K | 0.07% | +86,383 | New |
| Renaissance Technologies LLC | 80,576 | $247.0K | 0.00% | +34,200+73.7% | Added |
| Vanguard Group Inc | 69,633 | $213.8K | 0.00% | +20,051+40.4% | Added |
| Susquehanna International Group, LLP | 60,323 | $185.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 44,618 | $137.0K | 0.00% | −2,679−5.7% | Reduced |
| Northern Trust Corp | 36,951 | $113.4K | 0.00% | 00.0% | Unchanged |
| Staley Capital Advisers Inc | 36,472 | $112.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 16,199 | $50.0K | 0.00% | +16,199 | New |
| State Street Corp | 11,665 | $35.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 10,990 | $33.7K | 0.00% | −6,283−36.4% | Reduced |
| Bank of America Corp | 2,187 | $6.71K | 0.00% | −598−21.5% | Reduced |
| Morgan Stanley | 1,868 | $5.74K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,241 | $3.81K | 0.00% | +451+57.1% | Added |
| MB, Levis & Associates, LLC | 1,041 | $3.20K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 187 | $574 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 174 | $535 | 0.00% | +2+1.2% | Added |
| JPMorgan Chase & Co | 169 | $520 | 0.00% | +23+15.8% | Added |
| UBS Group AG | 16 | $49 | 0.00% | −830−98.1% | Reduced |
| Cornerstone Planning Group LLC | 2 | $6 | 0.00% | +2 | New |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −703,868−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −60,055−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,043−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −4,444−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Indiana Trust & Investment Management CO | 0 | $0 | 0.00% | −12−100.0% | Sold out |